ArticleChina CDC weekly2025
Smoking Prevalence in Urban and Rural Areas - China, 2024.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Efficacy and long-term engagement of a WeChat-integrated modality versus a traditional quitline on smoking cessation in China: a randomised controlled trial.BMC medicine · 2026Trial
- Cancer burden and control in China: landscape, trends and challenges.Nature reviews. Clinical oncology · 2026Review
- Age-Period-Cohort Analysis and Projections of Smoking-Attributable Upper Gastrointestinal Cancers Burden: A Comparative Study of China and the World.Cancer medicine · 2026Article
- Assessment of disease burden in 225 patients with SAPHO syndrome: a comprehensive study of clinical features and quality of life.Clinical rheumatology · 2026Article
- Secondhand Smoke Exposure Across Five Campus Settings and Its Association with Smoke-Free Policy Implementation Among Chinese College Students - China, 2025.China CDC weekly · 2026Article
- The quality of video information related to smoking cessation on mainstream short-video platforms in China: a cross-sectional study.BMC public health · 2026Article
- Hematologic malignancies burden in China compared with the United States 1990-2021 and projections to 2040.Discover oncology · 2026Article
- Lung cancer mortality trends in China from 2013 to 2021 and projections to 2030.Cancer biology & medicine · 2026Article
- Differences in AUTOS- and FTND-assessed dependence on various tobacco products among Chinese current tobacco/nicotine users.Scientific reports · 2026Article
- Tobacco dependence and associated factors among smokers aged 15 years and older in Wuxi, China: a cross-sectional study.BMC public health · 2026Article
- Prevalence of smoking and factors associated with smoking cessation among diabetic patients in Chongqing, China: A cross-sectional study.Tobacco induced diseases · 2026Article
- Attractiveness and determinants of different tobacco products among Chinese smokers and non-smokers: a web-based cross-sectional study.Frontiers in public health · 2026Article
- Secondhand smoke exposure among patients with coronary heart disease in a tertiary Grade A hospital in China: A qualitative study of lived experience and sociocultural challenges.Tobacco induced diseases · 2026Article
- Burden of colorectal cancer attributable to dietary risks in China from 1990 to 2021: findings from the Global Burden of Disease Study 2021.Frontiers in nutrition · 2025Article
- What types of tobacco control public service advertisements work for Chinese adolescents? A mixed-methods study.Tobacco induced diseases · 2025Article
- Spatial-temporal characteristics and prediction of ischemic heart disease burden in the working population aged 15 to 59 years in China.Frontiers in cardiovascular medicine · 2025Article
- Effectiveness of online tobacco control education: A cross-sectional study among healthcare professionals.Tobacco induced diseases · 2025Article
- A retrospective study of the clinical diagnosis and treatment of 158 cases of COVID-19.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: In 2018, the current and daily smoking prevalence among Chinese adults aged ≥15 years were 26.6% and 23.2%, respectively. What is added by this report?: In 2024, China's smoking prevalence among adults aged ≥15 years was 23.2% (current) and 20.3% (daily), with current smokers averaging 15.8 cigarettes/day and daily smokers initiating daily smoking at 22.4 years. Slim cigarette use accounted for 32.9% of current smokers. What are the implications for public health practice?: Sustained reduction in tobacco use requires multifaceted interventions and rigorous controls on tobacco industry tactics that disseminate deceptive marketing of purported harm-reduction products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.